The estimated Net Worth of Phillip Pang is at least $5.64 Milhão dollars as of 22 February 2024. Dr Pang owns over 14,568 units of Vir Biotechnology Inc stock worth over $1,958,369 and over the last 4 years he sold VIR stock worth over $2,897,961. In addition, he makes $780,464 as Exec. VP & Chief Medical Officer at Vir Biotechnology Inc.
Dr has made over 46 trades of the Vir Biotechnology Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 14,568 units of VIR stock worth $146,408 on 22 February 2024.
The largest trade he's ever made was exercising 80,000 units of Vir Biotechnology Inc stock on 2 January 2024 worth over $110,400. On average, Dr trades about 10,107 units every 30 days since 2020. As of 22 February 2024 he still owns at least 250,111 units of Vir Biotechnology Inc stock.
You can see the complete history of Dr Pang stock trades at the bottom of the page.
Dr. Phillip Pang M.D., Ph.D. is the Exec. VP & Chief Medical Officer at Vir Biotechnology Inc.
As the Exec. VP & Chief Medical Officer of Vir Biotechnology Inc, the total compensation of Dr D at Vir Biotechnology Inc is $780,464. There are 10 executives at Vir Biotechnology Inc getting paid more, with George Scangos having the highest compensation of $3,944,610.
Dr D is 46, he's been the Exec. VP & Chief Medical Officer of Vir Biotechnology Inc since . There are 19 older and 4 younger executives at Vir Biotechnology Inc. The oldest executive at Vir Biotechnology Inc is Phillip Sharp, 75, who is the Independent Director.
Phillip's mailing address filed with the SEC is C/O VIR BIOTECHNOLOGY, INC., 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158.
Over the last 5 years, insiders at Vir Biotechnology Inc have traded over $197,171,926 worth of Vir Biotechnology Inc stock and bought 6,960,011 units worth $139,246,875 . The most active insiders traders include Norbert W Bischofberger, Endurance (Cayman) Ltd Sb I..., eKristina Burow. On average, Vir Biotechnology Inc executives and independent directors trade stock every 7 days with the average trade being worth of $478,115. The most recent stock trade was executed by Janet Napolitano on 9 September 2024, trading 12,190 units of VIR stock currently worth $95,082.
vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world’s most challenging infectious diseases for which solutions are non-existent or inadequate. vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. the company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.
Vir Biotechnology Inc executives and other stock owners filed with the SEC include: